Miglietta et al. published that COX-2 immune positivity and percentage of positive cells correlated significantly with the size, grading, extent of primary tumor and vascular invasion of carcinoma but not with biological parameters (HR and ERBB2 status). This evidence concerns the gene ERBB2 and carcinoma.